INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

73,431 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
BA
Burkhart John A IIIPresident, US P&C, Skyward Grp
SKWDSkyward Specialty Insurance Group, Inc.
Tax withholding
F$129K
2,798 sh
Jan 12, 2026
Page 1507 of 1836
← PrevNext →
Jan 14, 2026
traded Jan 12, 2026
+2d
SEC Form 4

Evidence

16
BP
Bodnar Dan PKChief Information Officer
SKWDSkyward Specialty Insurance Group, Inc.
Tax withholding
F$94K
2,049 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$61K
5,400 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$76K
6,700 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
FJ
Fitzgerald Kevin JosephCSO & EVP, Head of Research
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$104K
280 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$91K
8,000 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
6,700 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
PD
Papadopoulos DidierPresident of Aircraft OEM
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
804 sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$63K
5,400 sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

16
DW
Duffy Sean WEVP & Chief Claims Officer
SKWDSkyward Specialty Insurance Group, Inc.
Tax withholding
F$97K
2,095 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Grant or award
A—
19.0K sh
Jan 11, 2026Jan 14, 2026
traded Jan 11, 2026
+3dSEC Form 4

Evidence

16
BP
Bodnar Dan PKChief Information Officer
SKWDSkyward Specialty Insurance Group, Inc.
Tax withholding
F$86K
1,868 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
FJ
Fitzgerald Kevin JosephCSO & EVP, Head of Research
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$238K
644 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
FJ
Fitzgerald Kevin JosephCSO & EVP, Head of Research
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$207K
562 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
8,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
6,700 sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

16
FJ
Fitzgerald Kevin JosephCSO & EVP, Head of Research
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$72K
197 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
BG
Bowles GregoryChief Policy Officer
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
894 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
ML
Morgan Gerald L.Director, CEO, EXECUTIVE VICE CHAIRMAN
TXRHTexas Roadhouse, Inc.
Open-market sale · 10b5-1 plan
SELL$936K
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
DP
Duffy Sean P.Director, Chief Executive Officer
OMDAOmada Health, Inc.
Option exercise
M$104K
40.8K sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

16
BA
Burkhart John A IIIPresident, US P&C, Skyward Grp
SKWDSkyward Specialty Insurance Group, Inc.
Tax withholding
F$121K
2,623 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
5,400 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

16
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$94K
8,000 sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

15
KL
Kao Lee10% Owner, General Manager
SCTHSecuretech Innovations, Inc.
Disposition to issuer
D—
2.60M sh
Jan 7, 2026Jan 14, 2026
traded Jan 7, 2026
+7dSEC Form 4

Evidence

15
RS
Rosenthal Michael StuartChief Operating Officer
MPMP Materials Corp. / DE
Tax withholding
F$694K
10.6K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

15
ZF
Zalenko Neal F.Director
GRFEAGLE CAPITAL GROWTH FUND, INC.
Small acquisition
L$1,067
100 sh
Dec 30, 2025Jan 14, 2026
traded Dec 30, 2025
+15dSEC Form 4

Evidence

15
CR
Corbett RyanChief Financial Officer
MPMP Materials Corp. / DE
Tax withholding
F$787K
12.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

15
WL
Wiesen Irving LDirector
PBSVPharma-Bio Serv, Inc.
Grant or award
A—
20.0K sh
Jan 10, 2026Jan 14, 2026
traded Jan 10, 2026
+4dSEC Form 4

Evidence

15
KL
Kao Lee10% Owner, General Manager
SCTHSecuretech Innovations, Inc.
Grant or award
A—
260 sh
Jan 7, 2026Jan 14, 2026
traded Jan 7, 2026
+7dSEC Form 4

Evidence

15
MW
Michel Kirk WheelerDirector, Chairman
PBSVPharma-Bio Serv, Inc.
Grant or award
A—
20.0K sh
Jan 10, 2026Jan 14, 2026
traded Jan 10, 2026
+4dSEC Form 4

Evidence

15
PD
Perlysky DovDirector
PBSVPharma-Bio Serv, Inc.
Grant or award
A—
20.0K sh
Jan 10, 2026Jan 14, 2026
traded Jan 10, 2026
+4dSEC Form 4

Evidence

15
SH
Spindel HowardDirector
PBSVPharma-Bio Serv, Inc.
Grant or award
A—
20.0K sh
Jan 10, 2026Jan 14, 2026
traded Jan 10, 2026
+4dSEC Form 4

Evidence

15
ZF
Zalenko Neal F.Director
GRFEAGLE CAPITAL GROWTH FUND, INC.
Small acquisition
L$53.6
5 sh
Jan 6, 2026Jan 14, 2026
traded Jan 6, 2026
+8dSEC Form 4

Evidence

15
RS
Rosenthal Michael StuartChief Operating Officer
MPMP Materials Corp. / DE
Tax withholding
F$580K
9,083 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

15
KC
Krebs Mark C.Board Advisor
FMFGFarmers & Merchants Bancshares, Inc.
Grant or award
A$4,510
265 sh
Jan 8, 2026Jan 14, 2026
traded Jan 8, 2026
+6dSEC Form 4

Evidence

14
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Derivative conversion
C—
200.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
KA
Kapadia Sandip AHead of Actuarial
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Grant or award
A—
3,997 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

13
JW
Juvenal Tobin WChief Commercial Officer
CSTLCASTLE BIOSCIENCES INC
Grant or award
A—
9,207 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

13
AF
Abbasi FarazDirector
LKFNLAKELAND FINANCIAL CORP
Grant or award
A—
650 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence